Alpha Cognition
Markets an oral Alzheimer’s treatment while developing related neurodegeneration programs.
$9.42
After-hours close+0.30 (+3.35%)
At close$9.12(−6.37%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.33 | — | — |
| Aug 2026 | −$0.39 | −$0.40 | −2.0% |
| May 2026 | −$0.41 | −$0.37 | +9.8% |
| Mar 2026 | −$0.27 | −$0.30 | −11.1% |
| Nov 2025 | −$0.43 | −$0.30 | +30.2% |
The latest year is open to everyone — the 20 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Jan 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.33 | — | — | $7.0M | — | — |
| Aug 13, 2026 | −$0.39 | −$0.40 | −2.0% | $4.4M | $6.0M | +36.9% |
| May 14, 2026 | −$0.41 | −$0.37 | +9.8% | $3.4M | $3.5M | +3.2% |
| Mar 26, 2026 | −$0.27 | −$0.30 | −11.1% | $3.2M | $2.8M | −12.4% |
| Nov 13, 2025 | −$0.43 | −$0.30 | +30.2% | $5.3M | $2.8M | −46.0% |
The latest year is open to everyone — the 20 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 15, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 12, 2024 | ||||||
| Mar 31, 2024 | ||||||
| Dec 31, 2023 | ||||||
| Sep 30, 2023 | ||||||
| Jun 30, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Dec 31, 2022 | ||||||
| Sep 30, 2022 | ||||||
| Jun 30, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Dec 31, 2021 | ||||||
| Sep 30, 2021 | ||||||
| Jun 30, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Jan 31, 2021 | ||||||
| Jan 31, 2020 | ||||||